iCAP treatment inhibits in vivo tumor growth in an NF1-associated MPNST xenograft mouse model. Based on these results, we next evaluated the in vivo antitumor activity of iCAP. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.